Previsioni di mercato per enzimi, kit e reagenti per biologia molecolare in Medio Oriente e Africa fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto (enzimi, kit e reagenti), applicazione (epigenetica, sequenziamento, biologia sintetica, reazione a catena della polimerasi e altro) e utente finale (aziende biotecnologiche e farmaceutiche, ospedali e centri diagnostici e istituti accademici e di ricerca)

TIPRE00025776 | Pages: 167 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

Introduzione al mercato

Il MEA è composto da tre paesi principali, vale a dire Emirati Arabi Uniti (EAU), Arabia Saudita e Sud Africa. L\'Arabia Saudita è il più grande mercato per enzimi, kit e strumenti di biologia molecolare. reagenti a causa della crescente industria farmaceutica e biotecnologica. Inoltre, il mercato è guidato da ampi progetti di ricerca intrapresi da numerosi istituti di ricerca in Arabia Saudita. Inoltre, è probabile che gli sviluppi nei centri delle strutture sanitarie in Sud Africa incrementino il mercato degli enzimi, dei kit e dei prodotti per biologia molecolare. reagenti durante il periodo di previsione. I paesi considerati per il resto della regione MEA sono Oman, Israele, Turchia, Siria. Nigeria, Etiopia, Egitto e Kenya. I paesi stanno aumentando significativamente gli investimenti per lo sviluppo del settore sanitario e hanno ampliato le opportunità per il settore privato. Ad esempio, secondo il rapporto di Alpen Capital, l\'Oman ha investito 1,5 miliardi di dollari nella creazione di un centro sanitario denominato Sultan Qaboos Medical City Complex a Barka. Il completamento del progetto è previsto nel 2021. Il Ministero della Salute e la Società nazionale per lo sviluppo e gli investimenti di Muscat sostengono l\'investimento. È probabile che tali investimenti incoraggino più investitori e migliorino le opportunità di crescita durante il periodo di previsione.  

Le incertezze economiche e i conflitti in corso stanno peggiorando la condizione nella regione. Ad esempio, paesi come Siria, Libia e Yemen sono colpiti da violenti conflitti e non possono attuare alcuna misura di sanità pubblica. L’Iran era in una profonda recessione economica a causa delle sanzioni statunitensi. Inoltre, la principale fonte di stabilizzazione economica nei paesi del Medio Oriente è la produzione e l’esportazione di petrolio. Tuttavia, la recente pandemia sta causando turbolenze alle economie della regione del Medio Oriente. Un improvviso calo della domanda interna ed esterna di beni e prodotti, in particolare di petrolio greggio, e l’arresto della produzione a causa della carenza di manodopera sono gli impatti principali osservati nella regione. Le politiche del governo saudita favoriscono i produttori farmaceutici nazionali, inclusa l\'assenza di dazi all\'importazione su materie prime e prodotti farmaceutici. prodotti intermedi e finanziamenti senza interessi, sostenendo così la crescita del mercato farmaceutico in questa regione. Allo stesso modo, la crescente incidenza di COVID-19 sta creando una massiccia domanda di kit e reagenti utilizzati per rilevare il virus COVID-19. Nell\'aprile 2020, BGI Group, una società cinese di genomica, e Group-42, una società tecnologica degli Emirati Arabi Uniti, hanno inaugurato un nuovo laboratorio ad alta produttività negli Emirati Arabi Uniti per aiutare con i test e la diagnosi del nuovo coronavirus. Secondo BGI, il laboratorio utilizzerà kit diagnostici RT-PCR approvati dalle autorità di regolamentazione medica in Cina, Europa, Stati Uniti e Giappone. Poiché gli enzimi, i kit e i reagenti di biologia molecolare vengono utilizzati principalmente per il rilevamento di un nuovo coronavirus, si è verificato un impatto elevato di COVID-19 sugli enzimi, sui kit e sui reagenti di biologia molecolare. mercato dei reagenti.            

Panoramica e dinamiche del mercato

Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare mercato nella MEA si prevede che crescerà da 537,68 milioni di dollari nel 2021 a 1.566,09 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 16,5% dal 2021 al 2028. Il costo e il tempo necessari per il sequenziamento dell\'intero genoma umano sono diminuiti significativamente dal 2000. È possibile accedere ai risultati su laptop o personal computer, utilizzando una chiavetta USB, e possono essere inoltre condivisi facilmente tramite Internet. Questa trasformazione nella procedura di sequenziamento genetico promette una rivoluzione per introdurre un’assistenza sanitaria più personalizzata ed efficace. Inoltre, la digitalizzazione consente ai medici di prendere decisioni sul trattamento del cancro di un paziente, sulla base della composizione genetica dei tumori o dei tessuti cancerosi. Questi progressi stanno rendendo la medicina di precisione una realtà consentendo lo sviluppo di terapie altamente mirate che offrono il potenziale per migliorare i risultati del trattamento, in particolare per i pazienti che combattono il cancro. La medicina personalizzata considera la variabilità genetica, ambientale e dello stile di vita.  

Segmenti chiave del mercato

Il mercato degli enzimi, kit e reagenti per biologia molecolare MEA è segmentato in prodotto, applicazione, utente finale e paese. In base al prodotto, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare è suddiviso in enzimi e kit e amp; reagenti. Il mercato, per enzimi, è ulteriormente segmentato in polimerasi, ligasi, trascrittasi inversa, fosfatasi, proteasi e proteinasi, endonucleasi di restrizione e altro. I kit e gli accessori Il segmento dei reagenti ha detenuto una quota di mercato maggiore nel 2020. Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare, in base all\'applicazione, è segmentato in epigenetica, sequenziamento, biologia sintetica, reazione a catena della polimerasi e altro. Nel 2020, il segmento del sequenziamento deteneva la quota di mercato maggiore. In termini di utente finale, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare è segmentato in aziende biotecnologiche e farmaceutiche, ospedali e centri diagnostici e istituti accademici e di ricerca. Il segmento delle aziende biotecnologiche e farmaceutiche ha detenuto la quota maggiore del mercato nel 2020. In base al paese, il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare è segmentato in Arabia Saudita, Sud Africa, Emirati Arabi Uniti e resto del MEA. Il resto del MEA ha detenuto la quota di mercato maggiore nel 2020.

Principali fonti e società elencate

Alcune principali fonti primarie e secondarie Le fonti a cui si fa riferimento per la preparazione di questo rapporto sul mercato degli enzimi, kit e reagenti per biologia molecolare nella MEA sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; e THERMO FISHER SCIENTIFIC INC.         

Motivi per acquistare il rapporto

  • Comprendere il panorama del mercato degli enzimi, dei kit e dei reagenti per biologia molecolare MEA e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno.
  • Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare MEA.
  • Pianifica in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nella biologia molecolare MEA mercato degli enzimi, dei kit e dei reagenti identificando i segmenti di mercato con le vendite probabili più promettenti.
  • Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni del mercato di vari segmenti sotto forma di enzimi, kit, prodotti per biologia molecolare MEA e mercato dei reagenti.
  • Ottieni previsioni sui ricavi del mercato per vari segmenti dal 2021 al 2028 nella regione MEA.

MEA Mercato degli enzimi, dei kit e dei reagenti per la biologia molecolare Segmentazione

MEA Mercato di enzimi, kit e reagenti per biologia molecolare - Per prodotto

  • Enzimi
    • Polimerasi
    • Ligasi
    • Trascrittasi inverse
    • Fosfatasi
    • Proteasi e proteinasi
    • Endonucleasi di restrizione
    • Altro
  • Kit e reagenti

Mercato degli enzimi, kit e reagenti per biologia molecolare MEA - A cura di Applicazione

  • Epigenetica
  • Sequenziamento
  • Biologia sintetica
  • Reazione a catena della polimerasi
  • Altro

Mercato degli enzimi, kit e reagenti per biologia molecolare - Per utente finale

< ul>
  • Aziende biotecnologiche e farmaceutiche
  • Ospedali e centri diagnostici
  • Istituti accademici e di ricerca
  • MEA Molecular Mercato degli enzimi, dei kit e dei reagenti per biologia - Per paese

    • Arabia Saudita
    • Sudafrica
    • Emirati Arabi Uniti
    • Resto del MEA

    Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare del MEA - Profili aziendali

    • Agilent Technologies, Inc.
    • F. HOFFMANN-LA ROCHE LTD
    • Illumina, Inc.
    • Merck KGAA
    • MERIDIAN BIOSCIENCE, INC
    • Promega Corporation
    • Qiagen
    • THERMO FISHER SCIENTIFIC INC
     

    TABLE OF CONTENTS

    1.           Introduction

    1.1         Scope of the Study

    1.2         The Insight Partners Research Report Guidance

    1.3         Market Segmentation

    1.3.1        MEA Molecular Biology Enzymes, Kits & Reagents Market – By Product

    1.3.2        MEA Molecular Biology Enzymes, Kits & Reagents Market – By Application

    1.3.3        MEA Molecular Biology Enzymes, Kits & Reagents Market – By End-User

    1.3.4        MEA Molecular Biology Enzymes, Kits & Reagents Market – By Country

    2.           MEA Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways

    3.           Research Methodology

    3.1         Coverage

    3.2         Secondary Research

    3.3         Primary Research

    4.           MEA Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape

    4.1         MEA PEST Analysis

    4.1.1        Expert Opinion

    5.           MEA Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics

    5.1         Market Drivers

    5.1.1        Genomics Getting Hefty Fundings

    5.1.2        Sequencing Procedures Getting Affordable

    5.1.3        Surge in Chronic Diseases Prevalence

    5.2         Market Restraints

    5.2.1        Skilled Professionals are in Scarce Supply

    5.3         Market Opportunities

    5.3.1        Molecular Diagnostics Getting More Widely Known

    5.4         Future Trends

    5.4.1        Personalized Medicines are in High Demand

    5.5         Impact analysis

    6.           Molecular Biology Enzymes, Kits & Reagents Market – MEA Analysis

    6.1         MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis

    7.           MEA Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product

    7.1         Overview

    7.2         MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)

    7.3         Enzymes

    7.3.1        Overview

    7.3.2        Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.3        Polymerases

    7.3.3.1          Overview

    7.3.3.2          Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.4        Ligase

    7.3.4.1          Overview

    7.3.4.2          Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.5        Reverse Transcriptases

    7.3.5.1          Overview

    7.3.5.2          Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.6        Phosphatases

    7.3.6.1          Overview

    7.3.6.2          Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.7        Proteases and Proteinases

    7.3.7.1          Overview

    7.3.7.2          Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.8        Restriction Endonuclease

    7.3.8.1          Overview

    7.3.8.2          Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.9        Other

    7.3.9.1          Overview

    7.3.9.2          Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    7.4         Kits and Reagents

    7.4.1        Overview

    7.4.2        Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    8.           MEA Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application

    8.1         Overview

    8.2         MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)

    8.3         Polymerase Chain Reaction

    8.3.1        Overview

    8.3.2        Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    8.4         Sequencing

    8.4.1        Overview

    8.4.2        Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    8.5         Synthetic Biology

    8.5.1        Overview

    8.5.2        Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    8.6         Epigenetics

    8.6.1        Overview

    8.6.2        Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    8.7         Others

    8.7.1        Overview

    8.7.2        Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    9.           MEA Molecular Biology Enzymes, Kits & Reagents Market – By End User

    9.1         Overview

    9.2         MEA Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)

    9.3         Biotechnological and Pharmaceutical Companies

    9.3.1        Overview

    9.3.2        Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    9.4         Hospitals and Diagnostic Centers

    9.4.1        Overview

    9.4.2        Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    9.5         Academic and Research Institutes

    9.5.1        Overview

    9.5.2        Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    10.        MEA Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis

    10.1      Overview

    10.1.1     MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)

    10.1.1.1       Saudi Arabia

    10.1.1.1.1       Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    10.1.1.1.2       Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

    10.1.1.1.3       Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

    10.1.1.1.4       Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

    10.1.1.1.5       Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

    10.1.1.2       South Africa

    10.1.1.2.1       South Africa: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    10.1.1.2.2       South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

    10.1.1.2.3       South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

    10.1.1.2.4       South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

    10.1.1.2.5       South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

    10.1.1.3       UAE

    10.1.1.3.1       UAE: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    10.1.1.3.2       UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

    10.1.1.3.3       UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

    10.1.1.3.4       UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

    10.1.1.3.5       UAE: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

    10.1.1.4       Rest of MEA

    10.1.1.4.1       Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    10.1.1.4.2       Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

    10.1.1.4.3       Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

    10.1.1.4.4       Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

    10.1.1.4.5       Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

    11.        Impact of COVID-19 Pandemic on Global Molecular Biology Enzymes, Kits & Reagents Market

    11.1      MEA: Impact Assessment of COVID-19 Pandemic

    12.        Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape

    12.1      Overview

    12.2      Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021

    12.3      Organic Growth Strategies

    12.3.1     Overview

    12.3.2     Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market

    12.4      Inorganic Growth Strategies

    12.4.1     Overview

    13.        Company Profiles

    13.1      HOFFMANN-LA ROCHE LTD.

    13.1.1     Key Facts

    13.1.2     Business Description

    13.1.3     Products and Services

    13.1.4     Financial Overview

    13.1.5     SWOT Analysis

    13.1.6     Key Developments

    13.2      MERCK KGaA

    13.2.1     Key Facts

    13.2.2     Business Description

    13.2.3     Products and Services

    13.2.4     Financial Overview

    13.2.5     SWOT Analysis

    13.2.6     Key Developments

    13.3      Illumina, Inc.

    13.3.1     Key Facts

    13.3.2     Business Description

    13.3.3     Products and Services

    13.3.4     Financial Overview

    13.3.5     SWOT Analysis

    13.3.6     Key Developments

    13.4      QIAGEN

    13.4.1     Key Facts

    13.4.2     Business Description

    13.4.3     Products and Services

    13.4.4     Financial Overview

    13.4.5     SWOT Analysis

    13.4.6     Key Developments

    13.5      Agilent Technologies, Inc.

    13.5.1     Key Facts

    13.5.2     Business Description

    13.5.3     Products and Services

    13.5.4     Financial Overview

    13.5.5     SWOT Analysis

    13.5.6     Key Developments

    13.6      THERMO FISHER SCIENTIFIC INC.

    13.6.1     Key Facts

    13.6.2     Business Description

    13.6.3     Products and Services

    13.6.4     Financial Overview

    13.6.5     SWOT Analysis

    13.6.6     Key Developments

    13.7      MERIDIAN BIOSCIENCE, INC.

    13.7.1     Key Facts

    13.7.2     Business Description

    13.7.3     Products and Services

    13.7.4     Financial Overview

    13.7.5     SWOT Analysis

    13.7.6     Key Developments

    13.8      Promega Corporation

    13.8.1     Key Facts

    13.8.2     Business Description

    13.8.3     Products and Services

    13.8.4     Financial Overview

    13.8.5     SWOT Analysis

    13.8.6     Key Developments

    14.        Appendix

    14.1      About The Insight Partners

    14.2      Glossary of Terms

    LIST OF TABLES

    Table 1.             Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 2.             Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

    Table 3.             Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 4.             Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 5.             South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 6.             South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

    Table 7.             South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 8.             South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 9.             UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 10.          UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

    Table 11.          UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 12.          UAE: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 13.          Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 14.          Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

    Table 15.          Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 16.          Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 17.          Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market

    Table 18.          Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market

    LIST OF FIGURES

    Figure 1.           MEA Molecular Biology Enzymes, Kits & Reagents Market Segmentation

    Figure 2.           MEA Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country

    Figure 3.           MEA Molecular Biology Enzymes, Kits & Reagents Market Overview

    Figure 4.           Kits and Reagents Segment Held Largest Share of MEA Molecular Biology Enzymes, Kits & Reagents Market

    Figure 5.           North America to Show Remarkable Growth During Forecast Period

    Figure 6.           MEA PEST Analysis

    Figure 7.           MEA Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints

    Figure 8.           MEA Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2020- 2028

    Figure 9.           MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)

    Figure 10.        MEA Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 11.        MEA Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 12.        MEA Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 13.        MEA Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 14.        MEA Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 15.        MEA Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 16.        MEA Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 17.        MEA Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 18.        MEA Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 19.        MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)

    Figure 20.        MEA Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21.        MEA Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22.        MEA Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23.        MEA Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24.        MEA Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25.        MEA Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)

    Figure 26.        MEA Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27.        MEA Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028  (US$ Million)

    Figure 28.        MEA Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028  (US$ Million)

    Figure 29.        MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)

    Figure 30.        MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)

    Figure 31.        Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    Figure 32.        South Africa: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028  (USD Million)

    Figure 33.        UAE: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    Figure 34.        Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

    Figure 35.        Impact of COVID-19 Pandemic in MEA Country Markets

    Figure 36.        Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market

    1. Agilent Technologies, Inc.
    2. F. HOFFMANN-LA ROCHE LTD
    3. Illumina, Inc.
    4. Merck KGAA
    5. MERIDIAN BIOSCIENCE, INC
    6. Promega Corporation
    7. Qiagen
    8. THERMO FISHER SCIENTIFIC INC
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA molecular biology enzymes, kits, and reagents market
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the MEA molecular biology enzymes, kits, and reagents market, thereby allowing players across the value chain to develop effective long-term strategies
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the molecular biology enzymes, kits, and reagents market, as well as those hindering it
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000